Alzaria Pharmaceutical Private Limited
About Alzaria Pharmaceutical Private Limited
Data last updated:
Alzaria Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC297346.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pramod Rabhadiya and Vijaykumar Ramkripal Gupta.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shop No.13 A Wing Bldg No.21 Gurukripa Chs Near Sahakar Cinema, Mumbai, Maharashtra, India – 400089.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.72 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹83,686 (net margin -48.7%) and EBITDA of -₹79,648 (EBITDA margin -46.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alzaria Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressShop No.13 A Wing Bldg No.21 Gurukripa Chs Near Sahakar Cinema, Mumbai, Maharashtra, India – 400089
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alzaria Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alzaria Pharmaceutical Private Limited, buy the company report.
Financials of Alzaria Pharmaceutical Private Limited
FY 2019 filings availableAlzaria Pharmaceutical Private Limited reported revenue of ₹1.72 Lakh (up 244% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 244% in the latest year. EBITDA fell 91% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹79,648 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹83,686 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -46.3% | |
| Net Profit Margin | -48.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Alzaria Pharmaceutical Private Limited, buy the company report.
Board of directors of Alzaria Pharmaceutical Private Limited
Alzaria Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Rabhadiya | Director | 13 Jul 2017 | 9 Years 4 Months | Current |
| Vijaykumar Ramkripal Gupta | Director | 13 Jul 2017 | 9 Years 4 Months | Current |
| Surendra Pandey | Director | 13 Jul 2017 | 9 Years 4 Months | Current |
Peer comparison
Alzaria Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Greenfield Flooring India Private Limited | ₹1.72 Lakh (FY 2025) | -66.0% | Ernakulam, Kerala, India | |||
| Pipercare Private Limited | ₹1.72 Lakh (FY 2023) | 50095.0% | Patna, Bihar, India | |||
| Logyesthesia Pharmaceuticals Private Limited | ₹1.72 Lakh (FY 2016) | Nanded, Maharashtra, India | ||||
| Amaris Sanitaryware Private Limited | ₹1.72 Lakh (FY 2024) | -95.0% | New Delhi, Delhi, India | |||
| Abhinandan Diamond Private Limited | ₹1.72 Lakh (FY 2023) | -100.0% | Surat, Gujarat, India | |||
| Alzaria Pharmaceutical Private Limitedthis company | ₹1.72 Lakh (FY 2019) | -₹83,686 | -48.7% | 244.0% | Mumbai, Maharashtra, India | |
| Spinco Life Sciences (India) Private Limited | ₹1.72 Lakh (FY 2025) | -82.0% | Chennai, Tamil Nadu, India | |||
| Marica International Private Limited | ₹1.72 Lakh (FY 2018) | -99.0% | Delhi, India | |||
| Neplar Pharmaceutical Private Limited | ₹1.72 Lakh (FY 2023) | -57.0% | Pinjore, Haryana, India | |||
| Hidden Tesla Services Private Limited | ₹1.72 Lakh (FY 2019) | Kengeri, Bangalore South, Karnataka, India | ||||
| Prevac Engineering and Solutions Private Limited | ₹1.72 Lakh (FY 2023) | Pune, Maharashtra, India |
To see the full peer comparison of Alzaria Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alzaria Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alzaria Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Alzaria Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Alzaria Pharmaceutical Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Sandeep Surajlal Gupta ceased to be Director on 25 Jun 2024.
Frequently asked questions
Alzaria Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2017 (9+ years old) and is registered under CIN U74999MH2017PTC297346.
Alzaria Pharmaceutical has 3 current directors:
- Pramod Rabhadiya - Director
- Vijaykumar Ramkripal Gupta - Director
- Surendra Pandey - Director
The latest financial statements of Alzaria Pharmaceutical on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Alzaria Pharmaceutical is U74999MH2017PTC297346. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alzaria Pharmaceutical was incorporated on 13 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Alzaria Pharmaceutical by revenue are Greenfield Flooring India Private Limited, Pipercare Private Limited, Logyesthesia Pharmaceuticals Private Limited, Amaris Sanitaryware Private Limited, Abhinandan Diamond Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sandeep Surajlal Gupta ceased to be Director on 25 Jun 2024. Pramod Rabhadiya was appointed as Director on 13 Jul 2017. Surendra Pandey was appointed as Director on 13 Jul 2017. Alzaria Pharmaceutical has 4 board changes on record in total.
The registered office of Alzaria Pharmaceutical is at Shop No.13 A Wing Bldg No.21 Gurukripa Chs Near Sahakar Cinema, Mumbai, Maharashtra, India – 400089.
Alzaria Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Alzaria Pharmaceutical is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.
Alzaria Pharmaceutical can be reached at its registered office: Shop No.13 A Wing Bldg No.21 Gurukripa Chs Near Sahakar Cinema, Mumbai, Maharashtra, India – 400089.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
